Hopstem Biotech is Biotechnology in China that focus on cell therapy treatments business. Founded in 2017. They cover business area such as researcher, developer, neural stem cell technology, stem cell therapy, neurological disorder, their research, patient, neruological disorder, their engineer induce pluripotent stem cell, embryonic stem cell, ESCs.
2017
( 7 years old in 2024 )
Cell Therapy Treatments
-
3rd Floor, Building 16, Zhongzi Science and Technology Park, No. 260
6 Street, Hangzhou Economic and Technological Development Zone
Hangzhou, Zhejiang 310018
China
Private
researcherdeveloperneural stem cell technologystem cell therapyneurological disordertheir researchpatientneruological disordertheir engineer induce pluripotent stem cellembryonic stem cellESCs
* We use standard office opening hours in near Hopstem Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Hopstem Biotech is Biotechnology business from China that founded in 2017 (7 years old in 2024), Hopstem Biotech business is focusing on Cell Therapy Treatments.
Hopstem Biotech headquarter office and corporate office address is located in 3rd Floor, Building 16, Zhongzi Science and Technology Park, No. 260 6 Street, Hangzhou Economic and Technological Development Zone Hangzhou, Zhejiang 310018 China.
Hopstem Biotech was founded in China.
In 2024, Hopstem Biotech is currently focus on cell therapy treatments sector.
Above is snippet of Google Trends for "cell therapy treatments" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Hopstem Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.